US Stock MarketDetailed Quotes

GLSI Greenwich LifeSciences

Watchlist
  • 13.530
  • -0.670-4.72%
Close Oct 18 16:00 ET
  • 13.700
  • +0.170+1.26%
Post 17:49 ET
177.85MMarket Cap-17126P/E (TTM)

Greenwich LifeSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
52.27%2.66M
13.21%2.54M
16.01%9.33M
-2.03%2.84M
5.03%2.5M
126.02%1.75M
12.66%2.24M
74.87%8.04M
21.77%2.89M
174.96%2.38M
Selling and administrative expenses
-4.00%353.53K
-17.06%342.69K
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
214.69%659.57K
-General and administrative expense
-4.00%353.53K
-17.06%342.69K
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
214.69%659.57K
Research and development costs
67.29%2.31M
20.06%2.19M
18.89%7.7M
-5.09%2.33M
25.22%2.16M
117.86%1.38M
10.06%1.83M
81.93%6.48M
19.10%2.46M
162.29%1.72M
Operating profit
-52.27%-2.66M
-13.21%-2.54M
-16.01%-9.33M
2.03%-2.84M
-5.03%-2.5M
-126.02%-1.75M
-12.66%-2.24M
-74.87%-8.04M
-21.77%-2.89M
-174.96%-2.38M
Net non-operating interest income expense
-54.19%54.72K
-44.91%64.01K
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
1,694.76%64.04K
Non-operating interest income
-54.19%54.72K
-44.91%64.01K
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
1,694.76%64.04K
Other net income (expense)
Income before tax
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
Income tax
Net income
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
Net income continuous Operations
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
Minority interest income
Net income attributable to the parent company
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
Basic earnings per share
-53.85%-0.2
-11.76%-0.19
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
-157.14%-0.18
Diluted earnings per share
-53.85%-0.2
-11.76%-0.19
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
-157.14%-0.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 52.27%2.66M13.21%2.54M16.01%9.33M-2.03%2.84M5.03%2.5M126.02%1.75M12.66%2.24M74.87%8.04M21.77%2.89M174.96%2.38M
Selling and administrative expenses -4.00%353.53K-17.06%342.69K4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K214.69%659.57K
-General and administrative expense -4.00%353.53K-17.06%342.69K4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K214.69%659.57K
Research and development costs 67.29%2.31M20.06%2.19M18.89%7.7M-5.09%2.33M25.22%2.16M117.86%1.38M10.06%1.83M81.93%6.48M19.10%2.46M162.29%1.72M
Operating profit -52.27%-2.66M-13.21%-2.54M-16.01%-9.33M2.03%-2.84M-5.03%-2.5M-126.02%-1.75M-12.66%-2.24M-74.87%-8.04M-21.77%-2.89M-174.96%-2.38M
Net non-operating interest income expense -54.19%54.72K-44.91%64.01K102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K1,694.76%64.04K
Non-operating interest income -54.19%54.72K-44.91%64.01K102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K1,694.76%64.04K
Other net income (expense)
Income before tax -60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M
Income tax
Net income -60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M
Net income continuous Operations -60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M
Minority interest income
Net income attributable to the parent company -60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M
Basic earnings per share -53.85%-0.2-11.76%-0.19-13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22-157.14%-0.18
Diluted earnings per share -53.85%-0.2-11.76%-0.19-13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22-157.14%-0.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data